Beck Mack & Oliver’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,200
Closed -$498K 194
2021
Q4
$498K Hold
5,200
0.01% 145
2021
Q3
$254K Hold
5,200
0.01% 184
2021
Q2
$261K Hold
5,200
0.01% 174
2021
Q1
$204K Buy
+5,200
New +$202K 0.01% 177

Other funds holding BXC

Beck Mack & Oliver's BXC Position: Q1 2022 in Review

Beck Mack & Oliver sold out of BlueLinx (BXC) in Q1 2022, closing a stake of 5,200 shares — an estimated $498K sold.

Beck Mack & Oliver first reported a position in BXC in Q1 2021 and held it in 4 quarters. The position peaked at $498K in Q4 2021. 163 funds tracked by Wall St. Rank hold BXC as of Q1 2022.

  • Beck Mack & Oliver reported no remaining BlueLinx position as of Q1 2022 after selling out during the quarter.
  • Beck Mack & Oliver sold 5,200 BlueLinx shares in Q1 2022, an estimated $498K.
  • Beck Mack & Oliver first reported a position in BlueLinx in Q1 2021 and held it in 4 quarters.
  • Beck Mack & Oliver's BlueLinx position peaked at $498K in Q4 2021.
  • 163 funds tracked by Wall St. Rank held BlueLinx as of Q1 2022.

Based on Beck Mack & Oliver's 13F filing for Q1 2022, filed 16 May 2022.